Pittsburgh, United States
D.Sole, founded in 2023, is at the forefront of technology-driven medical devices designed to address foot complications in diabetic patients with neuropathy. Their innovative product, a smart insole, leverages multimodal sensors to detect and monitor issues such as ulcers early in their development. This proactive approach aims to reduce the incidence of severe ulcers and avoid amputations.
Operating at the intersection of the Hardware, Health Care, and Medical Devices industries, D.Sole provides clinicians with vital data, enhancing preventative care and offering personalized solutions for diabetic individuals. The company is headquartered in the United States, marking it as an agile entrant into the healthcare sector.
The startup recently closed a $100.00K Pre Seed Round on 06 December 2023, funded by Innovation Works and AlphaLab Health. This funding highlights investor confidence in their innovative approach to diabetic foot care solutions.
